|
NanoLogix Inc. offers its BNF technology in controlled testing at the University of Texas-Texas Medical Center in Houston for the bacteria Group B Streptococcus (GBS) in pregnant women. Early results show NanoLogix BNF technology detects GBS in roughly 2-6 hours, as opposed to traditional Petri culture methods, which can take 72 hours or longer. Texas Medical Center physicians see the high-speed diagnostic capabilities of the NanoLogix technology as a key to faster detection of GBS in late-term pregnancies and a reduction in the overuse of antibiotics as a precautionary measure.
Physicians and staff at the University of Texas-Texas Medical Center began experiment with obstetrics applications for NanoLogix BNF technology in September 2009. Medical Center personnel are undertaking work to determine the smallest amount of GBS identifiable and the shortest test time achievable through the use of NanoLogix BNF technology.
www.nanologix.com
|